
The global digital pills market size was valued at USD 4.62 billion in 2024 and is expected to reach USD 8.78 billion by 2032, at a CAGR of 8.35% during the forecast period
This growth is driven by factors such as the integration of remote patient monitoring technologies, which enable real-time tracking of medication adherence and patient health, thereby enhancing treatment outcomes and fostering personalized care

